Merck Offers to Reduce Price of Antiretroviral Efavirenz in Thailand, Provide No-Cost Efavirenz, Testing, Treatment Access to Children
June 5, 2007
Merck has offered to reduce the price of its antiretroviral drug Efavirenz in Thailand, Vichai Chokewiwat, chair of the Government Pharmaceutical Organization and the Ministry of Public Health's Committee on Compulsory Licensing, said on Saturday, Thailand's Nation reports (Nation, 6/3). The Thai government in November 2006 issued a compulsory license to produce a lower-cost version of Efavirenz. Since then, the government and Merck have continued negotiations. Thai Health Minister Mongkol Na Songkhla last month announced the government was considering revoking its compulsory license for Efavirenz following recent talks with Merck (Kaiser Daily HIV/AIDS Report, 5/24).
Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2007 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.